1,2-distearoyllecithin has been researched along with Cancer of Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin Grace, VM; Reji, RM; Sundaram, V | 1 |
| Grace, VM | 1 |
| Benazzouz, F; Cordobes, MD; de Beco, V; Moretti, JL; Starzec, A | 1 |
3 other study(ies) available for 1,2-distearoyllecithin and Cancer of Lung
| Article | Year |
|---|---|
Enhanced expression of tumour suppressor RAR-β by DSPC nano-formulated lipo-ATRA in the lung of B16F10 cell-implanted C57BL6 mice and in A549 cells.
Topics: A549 Cells; Animals; Antineoplastic Agents; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Receptors, Retinoic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tretinoin | 2017 |
Inhibition of metastatic lung cancer in C57BL/6 mice by liposome encapsulated all trans retinoic acid (ATRA).
Topics: Animals; Antineoplastic Agents; Liposomes; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Phosphatidylcholines; Tretinoin | 2012 |
Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
Topics: Adenocarcinoma; Biological Transport; Breast Neoplasms; Carcinoma, Small Cell; Cholesterol; Drug Resistance, Multiple; Female; Humans; Kinetics; Liposomes; Lung Neoplasms; Mouth Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 1999 |